This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Foreign product alert

Archived – Neovidan

Starting date:
July 29, 2009
Posting date:
July 29, 2009
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Issue:
Important Safety Information, Undeclared Substance
Audience:
General Public
Identification number:
RA-12000830

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

Hong Kong Department of Health

Product name

Neovidan

Manufacturer / Place of origin

Unknown

Product description

Neovidan is promoted as "high potency nutrition" for the treatment of rheumatism (arthritic pain) and neuralgia (neuropathic pain). The product comes in blister packs of 10 capsules and, according to the packaging, is supplemented with vitamins H3, B1, B6 and B12.

Reason for warning

The Hong Kong Department of Health warned consumers not to buy or use the product Neovidan after it was found to contain undeclared prednisolone and mefenamic acid:

  • Prednisolone is a steroidal prescription drug used to treat inflammatory conditions such as arthritis and allergic reactions.
  • Mefenamic acid is a prescription drug in the family known as non-steroidal anti-inflammatory drugs (NSAIDs). It is use to treat pain, fever and inflammation.

Prednisolone and mefenamic acid should only be taken under the supervision of a health care practitioner.

Possible side effects

  • Side effects associated with prednisolone include irregular heartbeat, increased blood pressure, stomach ulcer, blood disorders, skin, muscle and bone damage, and nervous system disorders.
  • Side effects associated with mefenamic acid include gastrointestinal bleeding, anemia, kidney failure and reduced blood-clotting ability.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709

Images

Select thumbnail to enlarge - opens in a new window